(CION) Cion Investment - Overview
Stock: Senior Loans, Equity Warrants, Corporate Bonds, Secondary Debt, Middle-Market
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 15.66% |
| Yield on Cost 5y | 26.93% |
| Yield CAGR 5y | 33.02% |
| Payout Consistency | 98.2% |
| Payout Ratio | 47.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.2% |
| Relative Tail Risk | -1.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.21 |
| Alpha | -17.54 |
| Character TTM | |
|---|---|
| Beta | 0.668 |
| Beta Downside | 0.872 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.46% |
| CAGR/Max DD | 0.32 |
Description: CION Cion Investment December 27, 2025
CION Investment Corp. (NYSE:CION) is a Business Development Company that focuses on senior secured loan investments-ranging from unitranche and first-lien to mezzanine structures-in U.S. middle-market companies, typically deploying $5-$50 million per deal into firms with $25-$75 million of EBITDA.
In addition to debt, CION may take up to 30 % of its capital for equity-linked instruments (warrants, options) and selective public-equity or foreign-security positions, and it also trades in the secondary loan market. The firm avoids start-ups, turnarounds, or speculative business models.
Key operational metrics (as of the latest 10-K): total assets of roughly $1.2 billion, a portfolio-weighted yield of ~9 %, dividend yield of 8.5 %, and a leverage ratio around 1.5×. The average holding period is about 4-5 years, with exits pursued via IPOs, mergers, sales, or recapitalizations.
Sector exposure is heavily weighted toward high-tech, healthcare, business services, and industrials-areas that have shown resilient cash-flow generation in a low-interest-rate environment but are now facing margin pressure as the Fed’s policy rate hovers near 5 %.
Given the BDC’s sensitivity to credit spreads and interest-rate cycles, monitoring the U.S. middle-market loan demand index and the spread between BDC yields and U.S. Treasuries is essential for assessing upside potential.
For a deeper quantitative view, a quick look at ValueRay’s data tables can help you quantify CION’s yield and leverage trends.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 25.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 1.01 > 0.02 and ΔFCF/TA 100.6 > 1.0 |
| NWC/Revenue: -9.75% < 20% (prev 54.06%; Δ -63.81% < -1%) |
| CFO/TA 1.01 > 3% & CFO 60.7m > Net Income 25.9m |
| Net Debt (-29.0k) to EBITDA (26.0m): -0.00 < 3 |
| Current Ratio: 0.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.1m) vs 12m ago -2.57% < -2% |
| Gross Margin: 28.72% > 18% (prev 0.49%; Δ 2823 % > 0.5%) |
| Asset Turnover: 13.28% > 50% (prev 9.74%; Δ 3.54% > 0%) |
| Interest Coverage Ratio: -1.36 > 6 (EBITDA TTM 26.0m / Interest Expense TTM 93.5m) |
Altman Z'' -15.00
| A: -0.21 (Total Current Assets 165.0k - Total Current Liabilities 13.0m) / Total Assets 60.4m |
| B: -3.93 (Retained Earnings -237.2m / Total Assets 60.4m) |
| C: -0.13 (EBIT TTM -126.8m / Avg Total Assets 988.0m) |
| D: -6.07 (Book Value of Equity -237.2m / Total Liabilities 39.1m) |
| Altman-Z'' Score: -21.43 = D |
What is the price of CION shares?
Over the past week, the price has changed by -0.53%, over one month by -1.79%, over three months by +4.87% and over the past year by -4.64%.
Is CION a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CION price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.7 | 14.4% |
| Analysts Target Price | 10.7 | 14.4% |
| ValueRay Target Price | 12.1 | 29.8% |
CION Fundamental Data Overview January 27, 2026
P/E Forward = 6.4683
P/S = 1.9948
P/B = 0.6274
Revenue TTM = 131.2m USD
EBIT TTM = -126.8m USD
EBITDA TTM = 26.0m USD
Long Term Debt = unknown (none)
Short Term Debt = 40.0k USD (from shortTermDebt, last fiscal year)
Debt = 1.10b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -29.0k USD (from netDebt column, last quarter)
Enterprise Value = 1.59b USD (488.6m + Debt 1.10b - CCE 29.0k)
Interest Coverage Ratio = -1.36 (Ebit TTM -126.8m / Interest Expense TTM 93.5m)
EV/FCF = 26.15x (Enterprise Value 1.59b / FCF TTM 60.7m)
FCF Yield = 3.82% (FCF TTM 60.7m / Enterprise Value 1.59b)
FCF Margin = 46.27% (FCF TTM 60.7m / Revenue TTM 131.2m)
Net Margin = 19.78% (Net Income TTM 25.9m / Revenue TTM 131.2m)
Gross Margin = 28.72% ((Revenue TTM 131.2m - Cost of Revenue TTM 93.5m) / Revenue TTM)
Gross Margin QoQ = 63.05% (prev 56.92%)
Tobins Q-Ratio = 26.29 (Enterprise Value 1.59b / Total Assets 60.4m)
Interest Expense / Debt = 2.06% (Interest Expense 22.7m / Debt 1.10b)
Taxrate = 0.31% (107.0k / 34.0m)
NOPAT = -126.4m (EBIT -126.8m * (1 - 0.31%)) [loss with tax shield]
Current Ratio = 0.01 (Total Current Assets 165.0k / Total Current Liabilities 13.0m)
Debt / Equity = 51.61 (Debt 1.10b / totalStockholderEquity, last quarter 21.3m)
Debt / EBITDA = -0.00 (Net Debt -29.0k / EBITDA 26.0m)
Debt / FCF = -0.00 (Net Debt -29.0k / FCF TTM 60.7m)
Total Stockholder Equity = 589.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.63% (Net Income 25.9m / Total Assets 60.4m)
RoE = 4.40% (Net Income TTM 25.9m / Total Stockholder Equity 589.4m)
RoCE = -267.4% (out of range, set to none) (EBIT -126.8m / Capital Employed (Total Assets 60.4m - Current Liab 13.0m))
RoIC = -6.75% (negative operating profit) (NOPAT -126.4m / Invested Capital 1.87b)
WACC = 4.00% (E(488.6m)/V(1.59b) * Re(8.38%) + D(1.10b)/V(1.59b) * Rd(2.06%) * (1-Tc(0.00)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.07%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈60.7m ; Y1≈39.9m ; Y5≈18.2m
Fair Price DCF = 11.21 (EV 579.4m - Net Debt -29.0k = Equity 579.4m / Shares 51.7m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -12.04 | EPS CAGR: -44.65% | SUE: -2.55 | # QB: 0
Revenue Correlation: -4.43 | Revenue CAGR: 24.02% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.34 | Chg30d=+0.017 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.32 | Chg30d=+0.030 | Revisions Net=+1 | Growth EPS=-25.0% | Growth Revenue=-15.7%